We turn insoluble compounds into bioavailable therapeutics
The majority of new chemical entities emerging from today's drug discovery pipelines are too poorly water-soluble to enable reproducible bioavailability and efficacy after oral intake. This greatly hinders drug development and prevents patients from accessing potentially life-saving therapeutics.
At Harpago, we tackle this solubility problem through rigorous formulation design and development.
At Harpago, we tackle this solubility problem through rigorous formulation design and development.
OUR CUSTOMERS
WHY WORK WITH US ?
A specialist CDMO for drug solubility enhancement
- Technical focusWe focus solely on formulation design for poorly soluble small molecules. This technical focus enables us to develop better solutions than generalist CDMOs.
- Low overheadOur operational focus on early-phase formulation R&D allows us to work much more cost-effectively than manufacturing-CDMOs.
- DedicationOur founders are still closely involved in the day-to-day operations and ensure that every project is approached with diligence and dedication.
